Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention
Kei Nakachi(Saitama Cancer Center), Kazue Imai(Saitama Cancer Center), Satoshi Miyaké(Tokyo Medical and Dental University), Masami Suganuma(Saitama University), Satoru Matsuyama(Saitama Cancer Center)
Cited by 408
Related Papers
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
|Journal of Cancer Research and Clinical Oncology|1992|807
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
|Proceedings of the National Academy of Sciences|1988|602
Tumor Promotion by Inhibitors of ProteinZ Phosphatases 1 and 2A: The Okadaic Acid Class of Compounds
|Advances in cancer research|1993|310
Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver.
|PubMed|1994|290
Green tea: cancer preventive beverage and/or drug
|Cancer Letters|2002|209